First patient enrolls in MMRF’s Horizon Two clinical trial for newly diagnosed multiple myeloma treatment

AACR urges OMB to retract proposed rule on federally funded research

The American Association for Cancer Research is urging the White House Office of Management and Budget to rescind its recent proposed rule that would give the administration unprecedented political control over government-funded science.

NIH calls for comment on proposal to limit the number of RPGs per PI

NIH has published a request for information on its proposed policy that would cap the number of research project grants, or RPGs, for which an individual can simultaneously serve as principal investigator or multi-principal investigator.

Stanford Medicine proposes building an integrated care and research center in Redwood City

Stanford has unveiled plans to build an integrated clinical care and research center in Redwood City, CA. The institution plans to submit its formal updated project description to the city and host informational community webinars.

June 12, 2026

Vol.52 No.23

Clinical Roundup

Teclistamab improves outcomes in relapsed MM, phase III trial finds

An international phase III study showed that patients with relapsed multiple myeloma treated with teclistamab lived longer and remained in remission significantly longer than patients receiving standard therapies.

June 05, 2026

Vol.52 No.22

Clinical

When CAM is added to standard therapies, survival rates drop, observational study finds

As complementary and alternative medicines continue to gain acceptance beyond the margins of cancer treatment, results from a recent study from Yale School of Medicine published in JAMA Network Open suggests that some patients using CAM with their mainstream therapy may, in fact, be substituting alternative medicine for allopathic interventions.

START Center for Cancer Research, Baptist Health South Florida expand patient access to early-phase clinical trials

Baptist Health South Florida and the START Center for Cancer Research, the largest global network of fully dedicated, early-phase oncology clinical trial sites, announced plans to form a strategic collaboration.

May 29, 2026

Vol.52 No.21

First patient enrolls in MMRF’s Horizon Two clinical trial for newly diagnosed multiple myeloma treatment

YOU MAY BE INTERESTED IN

AACR urges OMB to retract proposed rule on federally funded research

NIH calls for comment on proposal to limit the number of RPGs per PI

Stanford Medicine proposes building an integrated care and research center in Redwood City

Teclistamab improves outcomes in relapsed MM, phase III trial finds

When CAM is added to standard therapies, survival rates drop, observational study finds

START Center for Cancer Research, Baptist Health South Florida expand patient access to early-phase clinical trials

Renew today!

Subscriber content

Never miss an issue!

Login